Follicular lymphoma

Show results for

Unknown (1449)
Genomics (493)
Transcriptomics (277)
Clinical (58)
Other (12)
Proteomics (12)
Genomic (5)
Methylation profiling (4)
Metabolomics (2)

Organisms

Homo sapiens (390)
Mus musculus (70)
Andropogon gerardi (10)
Bacteria (10)
Canis lupus familiaris (10)
Chromatiales bacterium OalgGamma1 (10)
Clavibacter nebraskensis NCPPB 2581 (10)
Cnidaria (10)
Ensifer adhaerens (10)
Fasciola (10)
Human alphaherpesvirus 1 strain 17 (10)
Human alphaherpesvirus 1 strain KOS (10)
Human betaherpesvirus 5 (10)
Human herpesvirus 2 strain 186 (10)
Mesocricetus auratus (10)
Miscanthus x giganteus (10)
Mus musculus (10)
Panicum virgatum (10)
Bos taurus (2)
Canis lupus familiaris (2)
Ignicoccus hospitalis (2)
Cavia porcellus (2)
Capra hircus (2)
Macaca mulatta (1)
Ovis aries (1)
Escherichia coli (1)
Rattus norvegicus (1)
Drosophila melanogaster (1)
Dictyostelium discoideum (1)
Saccharomyces cerevisiae (1)

Organisms

Homo sapiens (216)
Mus musculus (48)
Dictyostelium discoideum (1)
Saccharomyces cerevisiae (1)
Canis lupus familiaris (1)

Repository

ENA (322)
geo (228)
biostudies-arrayexpress (131)
EGA (101)
pride (10)
dbGaP (5)
ExpressionAtlas (4)
MetaboLights (2)
PanoramaPublic (1)
PeptideAtlas (1)

Tissue

Uterine cervix (3)
Breast (3)
Esophagus (3)
Large intestine (3)
Stomach (3)
Pancreas (3)
Ovary (3)
Uterus (3)
Urinary bladder (3)
Skin (3)
Prostate gland (3)
Thyroid gland (3)
Brain (3)
Lung (3)
Liver (3)
Kidney (3)
Mouth mucosa (2)
Skeletal muscle tissue (2)
Blood (2)
Musculature (1)
Hematopoietic system (1)
Peripheral nervous system (1)
Vulva (1)
Mucosa (1)
Connective tissue (1)
Bile duct (1)
Bone (1)
Placenta (1)
Gall bladder (1)
Adrenal gland (1)

Disease

Lymphoma (7)
Renal cell carcinoma (4)
Pancreatic adenocarcinoma (4)
Follicular thyroid carcinoma (4)
Gastric adenocarcinoma (4)
Hepatocellular carcinoma (4)
Bladder transitional cell carcinoma (4)
Invasive lobular carcinoma (4)
Head and neck squamous cell carcinoma (4)
Squamous cell lung carcinoma (4)
Cervical squamous cell carcinoma (4)
Ovarian adenocarcinoma (4)
Melanoma (4)
Cholangiocarcinoma (4)
Esophageal adenocarcinoma (4)
Lung adenocarcinoma (4)
Breast adenocarcinoma (4)
Chronic lymphocytic leukemia (4)
Cervical adenocarcinoma (3)
Glioblastoma multiforme (3)
Colorectal adenocarcinoma (3)
Prostate adenocarcinoma (3)
Sarcoma (3)
Endometrial adenocarcinoma (3)
Glioma (3)
Anaplastic astrocytoma (2)
Chondrosarcoma (2)
Hodgkins lymphoma (2)
Mesothelioma (2)
Bladder carcinoma (2)

Technology Type

Mass Spectrometry (10)
Bottom-up proteomics (4)
Shotgun proteomics (4)
Illumina HiSeq 2000 (2)
Illumina HiSeq 2000, ILLUMINA (2)
Affinity purification coupled with mass spectrometry proteomics (2)
Affymetrix SNP 6.0 (1)
Illumina HiSeq 2000, HumanMethylation450k Bead Chip - Genome Studio, Illumina Genome Analyzer IIx (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2000, Illumina HiSeq 2500 (1)
Mass spectrometry (1)
Mass spectrometry assay (1)
Data-dependent acquisition (1)
Data-independent acquisition (1)

Instrument Platform

Illumina NovaSeq 6000 (2)
Illumina HiSeq 2000 (1)
Illumina HiSeq 4000 (1)
Gas Chromatography MS - (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - alternating - reverse-phase (1)
LTQ FT Ultra (1)

Publication Date

2015 (40)
2025 (35)
2024 (31)
2014 (30)
2012 (27)
2021 (26)
2013 (25)
2011 (20)
2026 (20)
2023 (14)
2020 (14)
2017 (13)
2019 (13)
2010 (11)
2005 (11)
2016 (10)
2009 (10)
2022 (8)
2008 (7)
2018 (7)
2007 (2)
2006 (2)

UNIPROT ID/AC

A0A024R8H9 (1)
A0A024RC46 (1)
A0A075B6P5 (1)
A0A087WTX5 (1)
A0A087WWK8 (1)
A0A087WYL9 (1)
A0A087X130 (1)
A0A087X1V9 (1)
A0A0A0MR66 (1)
A0A0A0MSA7 (1)
A0A0C4DG89 (1)
A0A0C4DGT3 (1)
A0AVK6 (1)
A0FGR8 (1)
A0FGR8-2 (1)
A0FGR8-6 (1)
A2IPI2 (1)
A2RU30 (1)
A5A3E0 (1)
A6NC98 (1)
A6NFI3 (1)
A6NHL2 (1)
A6NHR9 (1)
A6NJJ0 (1)
A6NNZ2 (1)
A8CG34 (1)
A8MPP1 (1)
A8MUU1 (1)
A9IYQ1 (1)
B2RPK0 (1)

CHEBI ID

CHEBI:63550 (1)
CHEBI:14321 (1)
CHEBI:37154 (1)
CHEBI:35391 (1)
CHEBI:30916 (1)
CHEBI:17202 (1)
CHEBI:28300 (1)
CHEBI:15996 (1)
CHEBI:25523 (1)
CHEBI:13389 (1)
CHEBI:26806 (1)
CHEBI:17239 (1)
CHEBI:17677 (1)
CHEBI:6650 (1)
CHEBI:15713 (1)
CHEBI:17659 (1)
CHEBI:32816 (1)
CHEBI:17552 (1)
CHEBI:22653 (1)
CHEBI:15422 (1)
CHEBI:16761 (1)
CHEBI:30769 (1)

Metabolite Name

Citrate (2)
{4-[(Phenoxyacetyl)amino]phenoxy}acetic acid (1)
[4-(4-Hydroxy-2-quinazolinyl)phenyl]methanesulfonamide (1)
[1,3]Oxazolo[4,5-b]pyridin-2-ol (1)
[(Ethoxycarbothioyl)sulfanyl]acetic acid (1)
[(5-Bromo-1H-indol-3-yl)methyl]dimethylamine (1)
[(4-Fluorobenzyl)sulfonyl]acetic acid (1)
[(4,6-Diamino-2-pyrimidinyl)sulfanyl]acetic acid (1)
[(3,4,5-Trimethoxybenzoyl)amino]acetic acid (1)
[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(e)-3-phenylprop-2-enoyl]oxymethyl]oxan-2-yl] 3,4,5-trihydroxybenzoate (1)
[(2r,3s,4s,5r,6s)-6-[4-[6-[4-[(2s,3r,4s,5s,6r)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate (1)
Urea, N-[2-methyl-5-(1-piperidinylsulfonyl)-3-furanyl]-N'-phenyl- (1)
Urea, N-[2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl]-N'-propyl- (1)
Uhdoside A (1)
Thyroxine 4'-O-.beta.-D-glucuronide (1)
Thiophanic acid (1)
Tanegoside (not validated) (1)
Substance P (9-11) (1)
Squamatic acid (1)
Sphingomyelin d18 (1)
Sonchifolignan A (1)
Solorinic acid (1)
Smiglaside c (not validated) (1)
Silychrystin (1)
Selariscin b (1)
Secalonic acid b (1)
Robustaside D (1)
Robustaside A (1)
Rhizocarpic acid (1)
Radicicol (1)

First Public Date

2014 (54)
2024 (46)
2025 (34)
2026 (29)
2021 (25)
2015 (25)
2023 (21)
2022 (20)
2020 (17)
2019 (13)
2017 (12)
2018 (9)
2016 (9)
2013 (8)

Classification

protozoa (1)

Study status

Completed (39)
Terminated (11)
Withdrawn (3)
Active, not recruiting (2)
Not provided (1)
Recruiting (1)
Not yet recruiting (1)

Study type

Transcription profiling by array (79)
Interventional (56)
Comparative genomic hybridization by array (12)
ChIP-seq (11)
RNA-seq of coding RNA (9)
Unknown experiment type (5)
ChIP-chip by tiling array (3)
Methylation profiling by array (3)
Genotyping by array (2)
MicroRNA profiling by array (2)
Observational (2)
RNA-seq of non coding RNA from single cells (1)
Human - High-throughput sequencing (1)
Other (1)
RNA-seq of coding RNA from single cells (1)
RNA-seq of non coding RNA (1)

Release Date

2023 (153)
2021 (148)
2025 (148)
2022 (147)
2024 (122)
2020 (103)
2019 (99)
2018 (85)
2015 (84)
2014 (76)
2016 (69)
2017 (66)
2013 (49)
2012 (48)
2011 (46)
2009 (40)
2010 (31)
2026 (17)
2008 (13)
2005 (9)
2007 (8)
2002 (6)
2006 (4)
2003 (3)
2000 (3)
1998 (2)
2004 (1)

Lab affiliation

Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS) Technical University Munich Gregor-Mendel-Straße 4 85354 Freising GERMANY (1)
Department of Chemical & Systems Biology, Stanford University, USA (1)
Department of Medical Oncology, Harbin Medical University Cancer Hospital, Heilongjiang Cancer Institute, Harbin 150081, Heilongjiang Province, People闁炽儲鐛� Republic of China. (1)
Harbin Medical University Cancer Hospital, Heilongjiang Cancer Institute, Harbin 150081, Heilongjiang Province, People’s Republic of China. (1)
Head Proteomics Group, Leiden University Medical Center, Center for Proteomics and Metabolomics, PO Box 9600, Postal zone P1-Q, 2300 RC Leiden, The Netherlands (1)
Head of the mass spectrometry platform of the Institut Curie (LSMP) (1)
Laboratoire PRISM, Inserm U1192 (1)
Max Planck Institute of Biochemistry. Martinsried, Germany (1)
TIGEM (1)
Université Côte d’Azur, INSERM, C3M, 06204 Nice, France. CIRI, Université de Lyon; INSERM U1111; ENS de Lyon; University Lyon1; CNRS, UMR5308, 69007 Lyon, France (1)

Location

United States (54)
Italy (5)
India (2)
Canada (2)
Germany (2)
Brazil (1)

Keyword

Fludarabine (9)
Fludarabine phosphate (9)
Rituximab (9)
Mycophenolic Acid (8)
Cyclosporine (8)
Cyclosporins (8)
Antibodies (8)
Antibodies, Monoclonal (8)
Immunoglobulins (7)
Cyclophosphamide (6)
Antineoplastic Agents, Immunological (6)
Lenalidomide (5)
Etoposide (5)
Etoposide phosphate (5)
Tacrolimus (4)
Vorinostat (4)
Bendamustine Hydrochloride (3)
Busulfan (3)
Gemcitabine (3)
Histone Deacetylase Inhibitors (2)
Bortezomib (2)
Dexamethasone (2)
Liver Cancer (2)
Methotrexate (2)
Kidney Cancer (2)
Ipilimumab (2)
CDX-1140 (1)
GI Cancer (1)
Celldex (1)
CD40 (1)

Previous page
1 / 232
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 232
Next page

Sort by:

Relevance

Page size

microRNA profiling of follicular lymphoma cells

The hallmark of follicular lymphoma (FL) is the t(14;18) chromosomal translocation. However, constitutive expression of anti-apoptotic Bcl-2 alone is insufficient for lymphomagenesis and subsequent molecular hits are required. We explored the role of microRNA (miRNA or miR) in the biology of FL by...

ORGANISM(S): Homo sapiens

2012-05-02 | E-GEOD-28090 | biostudies-arrayexpress

Follicular lymphoma in situ and partial involvement by follicular lymphoma are clona lesions that carry the t(14;18) and lack genetic secondary alterations

Follicular lymphoma (FL) is characterized by the t(14;18)(q32;q21), frequent numerical chromosomal alterations, and recurrent somatic mutations. However, no genetic studies are available for FL in situ (FLIS), a putative precursor lesion of FL. In this study, we analyzed cases of FLIS without manife...

ORGANISM(S): Homo sapiens

2013-11-12 | E-GEOD-48548 | biostudies-arrayexpress

Lymph nodes with follicular lymphoma or reactive hyperplasia

Comparison of gene expression profiles of follicular lymphoma vs. reactive lymph nodes. 8 cases of follicular lymphoma; 5 cases of reactive lymph nodes.

ORGANISM(S): Homo sapiens

2011-09-26 | E-GEOD-14214 | biostudies-arrayexpress

Variation in gene expression patterns in follicular lymphoma and the response to rituximab

This SuperSeries is composed of the following subset Series: GSE3646: Follicular lymphoma and normal lymphoid tissue comparisons GSE3647: Follicular lymphoma lymph node Abstract: Analysis of the patterns of gene expression in follicular lymphomas from 24 patients suggested that two groups of tumors...

ORGANISM(S): Homo sapiens

2006-03-06 | E-GEOD-4351 | biostudies-arrayexpress

Transcription profiling of human follicular and transformed follicular lymphoma samples revals genome-wide detection of recurring sites of uniparental disomy

Follicular lymphoma (FL) is the second most common B-cell malignancy representing one quarter of Non-Hodgkin's Lymphomas. Although the disease has a relatively long median survival, the illness follows a fluctuating course of progression punctuated by remissions of variable duration. For as many as ...

ORGANISM(S): Homo sapiens

2008-06-17 | E-GEOD-7425 | biostudies-arrayexpress

Transcription profiling of follicular lymphoma to diffuse large cell lymphoma

Transformation of Follicular Lymphoma to Diffuse Large Cell Lymphoma: Alternative Patterns with Increased or Decreased Expression of c-myc and its Regulated genes The natural history of follicular lymphoma (FL) is frequently characterized by transformation to a more aggressive diffuse large ...

ORGANISM(S): Homo sapiens

2005-09-23 | E-SMDB-963 | biostudies-arrayexpress

Genome-wide copy number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

We studied 277 lymphoma samples (198 FL and 79 transformed FL [tFL]) using a single-nucleotide polymorphism array to identify the secondary chromosomal abnormalities that drive the development of FL and its transformation to diffuse large B-cell lymphoma. Affymetrix 250K NspI SNP arrays were perform...

ORGANISM(S): Homo sapiens

2015-03-30 | E-GEOD-67385 | biostudies-arrayexpress

Integrative profiling of follicular lymphoma at diagnosis and relapse

B-cells were purified from cyropreserved tumor cell suspensions by FACS, DNA isolated, and interogated using Affymetrix 250K Nsp SNP microarrays. Aim: To track the evolution of genetic alterations during progression of follicular lymphoma. One array per tumor.

ORGANISM(S): Homo sapiens

2015-03-02 | E-GEOD-56311 | biostudies-arrayexpress

Gene expression Profiling in Follicular Lymphomas

Follicular lymphoma (FL) is an indolent, but incurable subtype of non-Hodgkin lymphoma. These tumor harbor t (14;18) translocation in at least 90% of patients. Recently, activating EZH2 mutations have been Follicular lymphoma (FL) is an indolent, but incurable subtype of non-Hodgkin lymphoma. These ...

ORGANISM(S): Homo sapiens

2014-07-01 | E-GEOD-55267 | biostudies-arrayexpress

Comparative genomic hybridization by array of human lymphoma samples

Profiling of DNA copy number alterations by array CGH in 100 sequential samples from 44 patients diagnosed with follicular lymphoma using a inhouse 1 Mb BAC/PAC array CGH

ORGANISM(S): Homo sapiens

2010-11-03 | E-TABM-930 | biostudies-arrayexpress

Previous page
1 / 232
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 232
Next page

Sort by:

Relevance

Page size

2312 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

First Public Date

Classification

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets